Rapid diagnostic tests

SelfD Technologie

SelfD Technologie develops easy-to-use medical devices that help detect diseases at the Point-of-care.

Our NINAAT (Non-Instrumented Nucleic Acid Amplification Technology)-based diagnostics platform will be applicable for tests on infectious and genetic diseases. In addition, it will be used for companion diagnostics and assists both doctors and patients in making treatment decisions. SelfD Technologie's first product will be a quick home test to detect up to three sexually transmitted pathogens simultaneously; market launch is scheduled for 2018.

Since the company's foundation in 2012, SelfD Technologie has been assigning tasks to renowned research and development partners - among others to the Leipzig-based Fraunhofer Institute for Cell Therapy and Immunology.

Get in contact


The project owner is solely responsible for the content of this project description.